GlassScriptPhysician profile
Scott Butler
NPI 1750737920
$764.73
in general payments reported to CMS, 2019-2025
13 companies · $258 in 2025
The $258 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.40 · 2022: $27.62 · 2023: $134 · 2024: $319 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $711.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $710.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $197.64 | 2023-2025 | |
| Boston Scientific Corporation | $111.93 | 2023-2024 | Watchman Access System, Vigilant X4 Crt-D |
| Novartis Pharmaceuticals Corporation | $100.97 | 2022-2025 | |
| Amgen INC. | $68.75 | 2023-2024 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $65.26 | 2024-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $48.18 | 2023-2025 | Verquvo |
| Novo Nordisk INC | $34.54 | 2025 | Wegovy |
| Recor Medical INC | $26.85 | 2025 | Paradise Ultrasound Renal Denervation System |
| Kiniksa Pharmaceuticals International, Plc | $26.43 | 2024 | Arcalyst |
| Medtronic, INC. | $26.40 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $21.61 | 2023 | Arcalyst |
| Janssen Pharmaceuticals, INC | $18.68 | 2024 | Xarelto |
| Cvrx, INC. | $17.49 | 2025 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.